Bluejay Diagnostics, Inc. Additional Paid in Capital, Common Stock
Bluejay Diagnostics, Inc. (BJDX) had Additional Paid in Capital, Common Stock of $55.18 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital, Common Stock $55.18M.
- 2026-03-31: Additional Paid in Capital, Common Stock $47.62M.
- 2025-12-31: Additional Paid in Capital, Common Stock $47.49M.
- 2025-09-30: Additional Paid in Capital, Common Stock $43.78M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $55.18M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $47.62M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $47.49M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $43.78M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $43.78M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $40.40M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $40.40M 10-K · filed 2026-03-06 | $40.40M 10-K · filed 2025-03-31 |
| 2024-09-30 | $40.40M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $40.40M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $32.65M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $29.85M 10-K · filed 2025-03-31 | $29.85M 10-K · filed 2024-03-28 |
| 2023-09-30 | $29.86M 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $28.54M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |